Answers are grounded in this paper and cite their sources.
Patient‐derived tumor organoids (PDTOs) have emerged as a promising functional platform for precision oncology, yet their clinical translation remains constrained by heterogeneous evidence and insufficient methodological standardization. This study systematically reviewed the clinical utility and limitations of PDTO‐based drug sensitivity testing across different cancer types and treatment settings. PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov were searched from inception to June 18, 2026, and studies or registered clinical trials evaluating associations between PDTO drug sensitivity and clinical outcomes were included. A total of 54 studies and 97 registered clinical trials involving 17 cancer types were identified. The establishment success rates of PDTOs ranged from 31.25% to 100.00%, and drug sensitivity was predominantly evaluated using cell viability assays, although response thresholds varied considerably across studies. Quantitative synthesis of 31 studies showed that PDTO‐based drug sensitivity testing achieved a pooled sensitivity of 0.91 (95% CI, 0.83–0.95), specificity of 0.79 (95% CI, 0.65–0.88), and SROC AUC of 0.93 (95% CI, 0.90–0.95) for predicting treatment response. Concordance between PDTO predictions and clinical responses ranged from 53.33% to 100.00%, and PDTO sensitivity appeared to be associated with long‐term survival outcomes. Registered clinical trials encompassed 21 cancer types and were mainly observational, with most studies still ongoing. Overall, PDTOs show considerable potential as a functional drug sensitivity testing approach for predicting treatment response and guiding personalized therapy selection. However, further prospective validation, harmonization of methodologies, and standardized evaluation criteria are required before their widespread implementation in precision oncology.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: